#Kratom

US health officials have launched a major crackdown on kratom-related products, targeting an opioid-like compound known as 7-hydroxymitragynine—often called “7-OH”—after a surge of complaints from the dietary supplement industry and growing safety concerns among regulators and medical experts. The US Food and Drug Administration (FDA) recently announced its intention to classify 7-OH as a Schedule I controlled substance, placing it on par with substances like LSD and heroin, and recommending a nationwide ban pending Drug Enforcement Administration (DEA) review (WBRZ; Yahoo News; FDA).